hpv persistent
Showing 1 - 25 of 5,047
HPV-Related Cervical Carcinoma, Low-Grade Squamous Intraepithelial Lesions, HPV Infection Trial in Wenzhou (CO2)
Recruiting
- HPV-Related Cervical Carcinoma
- +3 more
- CO2
-
Wenzhou, Zhejiang, Chinafirst affiliated hospital of Wenzhou medical university
Sep 23, 2023
HPV, Oropharyngeal Cancer Trial in Houston (Balstilimab)
Not yet recruiting
- HPV
- Oropharyngeal Cancer
-
Houston, TexasM D Anderson Cancer Center
Dec 5, 2022
Human Papilloma Virus Infection, Human Papilloma Virus Integration, Cervical Intraepithelial Neoplasia Trial in Wuhan
Not yet recruiting
- Human Papilloma Virus Infection
- +4 more
- diagnostic cervical conization
-
Wuhan, Hubei, ChinaTongji Hospital affiliated to Tongji Medical College of Huazhong
Aug 19, 2022
HPV Positive Oropharyngeal Squamous Cell Carcinoma, HIV-1-infection, HPV Infection Trial in São Paulo, Cuernavaca, San Juan (9
Recruiting
- HPV Positive Oropharyngeal Squamous Cell Carcinoma
- +2 more
- 9 valent human papillomavirus vaccine (Types 6, 11, 16, 18, 31, 33, 45, 52, 58)
- Saline Placebo
-
São Paulo, Brazil
- +2 more
Mar 25, 2022
HPV Integration on the Prognosis of Persistent HR-HPV Infection
Recruiting
- HPV Infection
- +3 more
- Follow up
-
Fuzhou, Fujian, China
- +10 more
Mar 7, 2022
High Grade Cervical Intra-epithelial Neoplasia Trial in Montreal (high risk HPV DNA testing, Active comparator: Routine
Active, not recruiting
- High Grade Cervical Intra-epithelial Neoplasia
- high risk HPV DNA testing
- Active comparator: Routine colposcopy
-
Montreal, Quebec, CanadaCentre de recherche du CHUM
Jul 28, 2021
Cervical Intraepithelial Neoplasia, Cervical Cancer, Vaginal Intraepithelial Neoplasia Trial in Dongtai (Recombinant Human
Completed
- Cervical Intraepithelial Neoplasia
- +4 more
- Recombinant Human Papillomavirus Bivalent (Types 16, 18) Vaccine (Escherichia coli) / Cecolin®
-
Dongtai, Jiangsu, ChinaDongtai City Center for Disease Control and Prevention Dongtai,
Jun 22, 2022
High Grade Squamous Intra-epithelial Lesion (HSIL) Trial in Darlinghurst (Pomalidomide 2 MG Oral Capsule [Pomalyst])
Active, not recruiting
- High Grade Squamous Intra-epithelial Lesion (HSIL)
- Pomalidomide 2 MG Oral Capsule [Pomalyst]
-
Darlinghurst, New South Wales, AustraliaSt Vincent's Hospital
Mar 28, 2022
The Durability of Protection and Immuno-persistence Study
Recruiting
- Cervical Intraepithelial Neoplasia
- +4 more
- Recombinant Human Papillomavirus Bivalent (Types 16, 18) Vaccine (Escherichia coli)
-
Zhengzhou, Henan, ChinaHenan Cancer Hospital
Sep 14, 2021
Recombinant HPV 16/18 Bivalent Vaccine in Female
Recruiting
- Cervical Intraepithelial Neoplasia
- +4 more
- Recombinant Human Papillomavirus Bivalent (Types 16, 18) Vaccine (Escherichia coli)
-
Beijing, Beijing, ChinaPeking University People's Hospital
Jul 13, 2021
Global Burden Estimation of Human Papillomavirus (GLOBE-HPV)
Not yet recruiting
- HPV Infection
- Urine Sample Collection
- +2 more
-
Dhaka, Bangladesh
- +7 more
Nov 10, 2023
Women's Values in Managing Human Papillomavirus (HPV)
Not yet recruiting
- Human Papilloma Virus Infection
- No intervention
- (no location specified)
Nov 6, 2023
HPV Infection, HPV Vaccination Trial in Thika (Quadrivalent Human Papillomavirus (Types 6,11,16,18) Recombinant Vaccine)
Recruiting
- HPV Infection
- HPV Vaccination
- Quadrivalent Human Papillomavirus (Types 6,11,16,18) Recombinant Vaccine
-
Thika, Kiambu, KenyaPhrd-Ccr-Kemri
Jun 22, 2022
Papillomavirus Infections Trial in China (9vHPV Vaccine, Placebo)
Active, not recruiting
- Papillomavirus Infections
- 9vHPV Vaccine
- Placebo
-
Bejing, Beijing, China
- +33 more
Nov 16, 2022
HPV Vaccine Effectiveness Study in Rwandan Women Living With HIV
Recruiting
- Cervical Cancer
- +3 more
- Blood collection
- +5 more
-
Kigali, RwandaRwanda Military Hospital
Feb 9, 2022
Papillomavirus Infections Trial in Worldwide (9vHPV Vaccine, Placebo (Saline for Injection))
Active, not recruiting
- Papillomavirus Infections
- 9vHPV Vaccine
- Placebo (Saline for Injection)
-
Northridge, California
- +102 more
Aug 17, 2022
HPV Trial in Houston (PRECEDE-PROCEED)
Recruiting
- HPV
- PRECEDE-PROCEED
-
Houston, TexasM D Anderson Cancer Center
Oct 30, 2023
Cervical Dysplasia, HPV Infection Trial in Ulaanbaatar (gel Interferon arm, gel Interferon and interferon suppository arm)
Recruiting
- Cervical Dysplasia
- HPV Infection
- gel Interferon arm
- gel Interferon and interferon suppository arm
-
Ulaanbaatar, MongoliaNational Cancer Center
Nov 14, 2023
High Grade Anal Canal Intraepithelial Neoplasia, High Grade Vulvar Squamous Intraepithelial Lesion Trial in Birmingham, Seattle
Terminated
- High Grade Anal Canal Intraepithelial Neoplasia
- High Grade Vulvar Squamous Intraepithelial Lesion
- Laboratory Biomarker Analysis
- +3 more
-
Birmingham, Alabama
- +1 more
Jan 24, 2023
Human Papillomavirus Infections Trial in Montréal, Québec (Quadrivalent HPV vaccine)
Completed
- Human Papillomavirus Infections
- Quadrivalent HPV vaccine
-
Montréal, Quebec, Canada
- +1 more
Apr 21, 2022
Papilloma Viral Infection, CIN1, LSIL, Low Grade Squamous Intraepithelial Lesion Trial in Madrid (Glizigen, Placebo)
Recruiting
- Papilloma Viral Infection
- +2 more
- Glizigen
- Placebo
-
Madrid, Spain
- +3 more
Jun 27, 2023
Warts, Genital, Tumors, Anal Trial in Japan (V503, Placebo)
Active, not recruiting
- Warts, Genital
- Neoplasms, Anal
- V503
- Placebo
-
Takasaki, Gunma, Japan
- +21 more
Jan 6, 2022
Human Papilloma Virus, Anogenital Wart Trial in Zagazig (the Quadrivalent Vaccine (Gardasil))
Recruiting
- Human Papilloma Virus
- Anogenital Wart
- the Quadrivalent Vaccine (Gardasil)
-
Zagazig, EgyptRana Ehab
Feb 26, 2023
Papillomavirus Vaccines Trial in United States (HPV-PROTECT)
Recruiting
- Papillomavirus Vaccines
- HPV-PROTECT
-
Birmingham, Alabama
- +5 more
May 6, 2022